Mounjaro vs Ivim Health

Compare pricing, features, and medications to find the best GLP-1 provider for your weight loss journey

Mounjaro vs Ivim Health: Overview

Choosing between Mounjaro and Ivim Health for GLP-1 weight loss medication? Both are highly-rated providers, but they differ in pricing, medication options, and service features.

Mounjaro focuses on tirzepatide at $1080/month with a rating of 9.2/10. Ivim Health also provides both semaglutide and tirzepatide at $150/month with a 8.5/10 rating.

The price difference of $930/month is significant - Ivim Health is the more budget-friendly option, while Mounjaro positions itself as a premium service.

VERIFIED

Our recommended brand

After reviewing all 148 providers on this platform, we've identified CoreAge Rx as offering the most transparent pricing model. At just $99/month — the same price every month, every dose — there are no surprise charges or hidden fees. Combined with exceptional service quality, personalized support, and access to both semaglutide and tirzepatide, it represents the best value without compromising on care.

At a glance

Price Difference
$930/mo
Rating Difference
0.7
Winner
Mounjaro
Best For
Quality

Mounjaro

View full Mounjaro review →
Rating
9.2/10Better
Monthly Price
$1080
Medications
tirzepatide

Pros

  • FDA-approved for type 2 diabetes
  • Weekly injection
  • Effective for weight loss (~15-20%)
  • Dual GIP/GLP-1 mechanism
  • Often covered by insurance for diabetes

Cons

  • Primarily approved for diabetes, not weight loss
  • Requires prescription
  • May cause nausea and digestive issues
  • Supply shortages reported
Choose Mounjaro

Ivim Health

View full Ivim Health review →
Rating
8.5/10
Monthly Price
$150Cheaper
Medications
semaglutidetirzepatide

Pros

  • The mandatory program fee is shown next to the medication price rather than buried in a footnote: compounded semaglutide from $75/mo and tirzepatide from $133/mo, each plus a $74.99/mo program fee (checked July 27, 2026)
  • Trustpilot rating of 4.9 from 38,826 reviews - the largest and strongest independent signal of any brand we have reviewed
  • Efficacy claims are sourced to Ivim's own published study, with the comparator spelled out and an explicit note that it was 'Not a head-to-head study'
  • The compounded, not-FDA-approved disclosure is stated plainly alongside the results claims rather than in a distant footer
  • The GLP-1 ID model offers weekly provider check-ins and weekly dose adjustments, which is more active titration support than most competitors provide
  • Brand-name options are available too - Wegovy pill, Foundayo pill, Zepbound, Mounjaro, Ozempic, Wegovy, Saxenda and liraglutide
  • Plan lengths are selectable at checkout (1, 2, 4 or 6 months) rather than defaulting to a single long commitment
  • This offer is restricted in only two states, Mississippi and Washington

Cons

  • The $74.99 monthly program fee effectively doubles the cost of the entry semaglutide plan, taking a '$75/mo' headline to about $150 all-in
  • The advertised 'starting at' rates depend on plan length, and the default 'Jumpstart' option is a 4-month commitment - so the cheapest prices are not available month to month
  • The headline result, that patients 'lost an average of 46% more weight over 68 weeks', comes from Ivim's own study rather than independent research, and the comparator was diet, exercise and counselling rather than another GLP-1 provider
  • Add-on benefits are quantified with unverifiable price tags - '1:1 Virtual Holistic Consultations $850 value' and 'Master classes, group coaching & community $500 value'
  • The weight-loss calculator produces a specific projection (41.8 lbs on the default settings) that no individual can rely on
  • The supplement catalogue is very large - collagen, NMN, creatine, colostrum, berberine and more - so there is a persistent upsell layer around the medical service
  • No published customer phone number or support hours
  • No BBB profile or complaint history to set against the Trustpilot score
Choose Ivim Health

Feature-by-feature comparison

FeatureMounjaroIvim Health
Monthly Price$1080$150
Rating9.2/108.5/10
Medicationstirzepatidesemaglutide, tirzepatide
Insurance AcceptedYesNo
Support HoursMon-Fri 8AM-8PM ETNot published
Live ChatNoNo
Free ShippingNoYes
Shipping SpeedVaries by pharmacyNot published
Mobile AppNoAvailable
Dedicated CoachNot includedIncluded
Follow-up FrequencyAs prescribed by physicianWeekly provider check-ins with weekly dose adjustments
Money-back GuaranteeSavings card available ($25 per month for eligible patients)A refund policy is published; no blanket money-back guarantee is advertised
Cancellation PolicyPrescription-based, consult doctorPrograms run for the duration selected at checkout - 1, 2, 4 or 6 months - with 4 months the default Jumpstart option

Which should you choose?

Choose Mounjaro if you:

  • Prefer a higher-rated service (9.2/10 vs 8.5/10)
  • Need insurance coverage for your treatment
  • Value: fda-approved for type 2 diabetes

Choose Ivim Health if you:

  • Want to save $930/month with a more affordable option
  • Want more medication options to choose from
  • Want personalized coaching support included
  • Value: the mandatory program fee is shown next to the medication price rather than buried in a footnote: compounded semaglutide from $75/mo and tirzepatide from $133/mo, each plus a $74.99/mo program fee (checked july 27, 2026)

Website previews

Mounjaro

Mounjaro website

Ivim Health

Ivim Health website

Our recommendation

Mounjaro comes out ahead with a higher rating of 9.2/10.
Get started with Mounjaro

Compare other providers

Compare GLP-1 Brands